Post-exposure anti-rabies prophylaxis in Lublin province (Eastern Poland) in 2004-2005.
Rabies is considered a disease of the highest mortality rate and all humans are vulnerable to infection. Specific anti-rabies immunoprophylaxis is the only efficient method of protection. The analysis of indications for active alone and active and passive immunization among patients reported to the dispensary of rabies prophylaxis in the Department of Infectious Diseases of Medical University of Lublin (eastern Poland) in 2004-2005 is presented. Prophylactic procedures were applied in 120 persons (14.98 % of overall number consulted). Passive immunization, i.e. rabies immune globulin, was administered in 1 person (0.12 %). In 2004, 64 persons (7.99 %) received active vaccination, and 56 patients (6.99 %) were vaccinated in 2005. Most of vaccinated patients lived in an urban area where the risk of rabies should be lower; however, in cities like Lublin there is a higher risk of being bitten by homeless animals. The most common species with rabies suspicion were dogs and cats. The decrease in the number of patients bitten by animals with confirmed rabies in Lublin province, and of the number of cases of animal rabies may indicate that oral vaccination of red foxes, representing a main reservoir of rabies virus in Poland, has been shown to be effective.
Tomasiewicz
Krzysztof
K
Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20-089 Lublin, Poland. tomaskdr@tlen.pl
Fota-Markowska
Hanna
H
Krzowska-Firych
Joanna
J
Krawczuk
Grazyna
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000829:Animals, Domestic; D000835:Animals, Wild; D019072:Antibiotic Prophylaxis; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration; D007223:Infant; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D011818:Rabies / Q000453:epidemiology*; D011819:Rabies Vaccines / Q000627:therapeutic use*; D012189:Retrospective Studies; D012424:Rural Population / Q000706:statistics & numerical data; D014505:Urban Population / Q000706:statistics & numerical data
D011819:Rabies Vaccines